Méningiomes intracrâniens et utilisation prolongée d’acétate de cyprotérone à dose conventionnelle chez la femme : à propos de deux cas de régression tumorale après arrêt du traitement-Reference-Cited by-同舟云学术

Méningiomes intracrâniens et utilisation prolongée d’acétate de cyprotérone à dose conventionnelle chez la femme : à propos de deux cas de régression tumorale après arrêt du traitement

Published:2015-10 Issue:5 Volume:61 Page:339-342
ISSN:0028-3770
Container-title:Neurochirurgie
language:fr
Short-container-title:Neurochirurgie

Author:

Botella C.,Coll G.,Lemaire J.-J.,Irthum B.^ORCID

Publisher

Elsevier BV

Subject

Clinical Neurology,Surgery

Reference10 articles.

1. Prescription Andocur,2012

2. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas;Pravdenkova;J Neurosurg,2006

3. Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient;Cebula;Acta Neurochir (Wien),2010

4. Does cyproterone acetate promote multiple meningiomas?;Froelich,2008

5. Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study;Gil;Br J Clin Pharmacol,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiological evolution of progestogen‐induced meningioma: A monocentric retrospective study;Fundamental & Clinical Pharmacology;2023-02-03

2. Meningioma in patients exposed to progestin drugs: results from a real-life screening program;Journal of Neuro-Oncology;2022-09-06

3. Meningioma in patients exposed to progestin drugs: results from a real-life screening program;2022-08-08

4. A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas;Scientific Reports;2022-02-04